Major Shareholding Notification • Apr 7, 2014
Major Shareholding Notification
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 2405E
Alliance Pharma PLC
07 April 2014
| For immediate release | 7 April 2014 |
("Alliance" or the "Company")
TR-1: Notification of Major Interest in Shares
| 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: |
Alliance Pharma plc | |||
| 2 Reason for the notification (please tick the appropriate box or boxes): | ||||
| An acquisition or disposal of voting rights | x | |||
| An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||
| An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||
| An event changing the breakdown of voting rights | ||||
| Other (please specify): | ||||
| 3. Full name of person(s) subject to the notification obligation: |
Brown Shipley & Co Limited | |||
| 4. Full name of shareholder(s) (if different from 3.): | N/A | |||
| 5. Date of the transaction and date on which the threshold is crossed or reached: |
04/04/2014 | |||
| 6. Date on which issuer notified: | 07/04/2014 | |||
| 7. Threshold(s) that is/are crossed or reached: |
3.01% | |||
| 8. Notified details: | |||||||||||
| A: Voting rights attached to shares | |||||||||||
| Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
Resulting situation after the triggering transaction | |||||||||
| Number of Shares |
Number of Voting Rights |
Number of shares |
Number of voting rights |
% of voting rights | |||||||
| Direct | Direct | Indirect | Direct | Indirect | |||||||
| 7,815,845 | 7,815,845 | 7,941,145 | 7,941,145 | 3.01% | |||||||
| GG0031030819 | |||||||||||
| B: Qualifying Financial Instruments | |||||||||||
| Resulting situation after the triggering transaction | |||||||||||
| Type of financial instrument |
Expiration date |
Exercise/ Conversion Period |
Number of voting rights that may be acquired if the instrument is exercised/ converted. |
% of voting rights |
|||||||
| C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||
| Resulting situation after the triggering transaction | ||||||
| Type of financial instrument |
Exercise price | Expiration date | Exercise/ Conversion period |
Number of voting rights instrument refers to | % of voting rights | |
| Nominal | Delta | |||||
| Total (A+B+C) | |
| Number of voting rights | Percentage of voting rights |
| 7,815,845 | 3.01% |
| 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: |
||
| Proxy Voting: | ||
| 10. Name of the proxy holder: | ||
| 11. Number of voting rights proxy holder will cease to hold: |
||
| 12. Date on which proxy holder will cease to hold voting rights: |
||
| 13. Additional information: | ||
| 14. Contact name: | Kieron Brooks | |
| 15. Contact telephone number: | 020 7282 3206 | |
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLXDLFBZZFZBBB
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.